{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:54:30Z","timestamp":1784296470192,"version":"3.55.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"Background:<\/jats:bold>Congenital nephrotic syndrome of the Finnish type (CNF) is a rare, severe glomerular disease caused by mutations in the NPHS1 gene, which codes for nephrin. It is characterised by massive proteinuria and severe edoema. Progression to end-stage kidney failure occurs during early childhood and the only curative treatment is kidney transplantation. Nowadays, patients need aggressive medical treatment, which includes daily albumin infusions (for months) until they get clinical stability to receive transplant.<\/jats:p>Objective:<\/jats:bold>In our paediatric hospital, we implemented a multidisciplinary program for the home infusion of albumin with outpatient follow-up. The aim of the study was to assess the safety and efficacy of this program for the first four years of its implementation.<\/jats:p>Material and Methods:<\/jats:bold>Retrospective observational study of CNF paediatric patients treated with home albumin infusion therapy from March 2014 to July 2018 at a tertiary care paediatric hospital. Information on albumin administration was obtained from the electronic prescription assistance program and details on clinical and care-related variables from the hospital's electronic information systems.<\/jats:p>Results:<\/jats:bold>Four patients with CNF received albumin infusions for 18, 21, 22 months, and 3 years. The treatment was safe, and the complication rates were to be expected considering the severity of disease. Patients required a median of two hospital admissions a year (19 in total); 47% due to catheter-related complications, but there were just three catheter infections.<\/jats:p>Conclusions:<\/jats:bold>In our experience, home albumin infusion therapy is safe and effective and helps to improve children health and quality of life.<\/jats:p>","DOI":"10.3389\/fped.2020.614535","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T19:33:58Z","timestamp":1610652838000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Home Albumin Infusion Therapy, Another Alternative Treatment in Patients With Congenital Nephrotic Syndrome of the Finnish Type"],"prefix":"10.3389","volume":"8","author":[{"given":"Eug\u00e8nia","family":"Serramontmany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Fern\u00e1ndez-Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Morillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"G\u00f3mez-Ganda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carme","family":"Ca\u00f1ete-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Ariceta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,14]]},"reference":[{"key":"B1","unstructured":"P. Anales de pediatr\u00eda continuada: APC17242014"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/ndt\/gfv355","article-title":"Genetic testing in steroid-resistant nephrotic syndrome: when and how?","volume":"31","author":"Lovric","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B3","article-title":"Nefrolog\u00eda Pedi\u00e1trica","author":"Anton","year":"2011","journal-title":"Manual Pr\u00e1ctico"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s00467-007-0633-9","article-title":"Congenital nephrotic syndrome","volume":"24","author":"Jalanko","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF00858984","article-title":"Management of congenital nephrotic syndrome of the Finnish type","volume":"9","author":"Holmberg","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e907","DOI":"10.1542\/peds.2006-2164","article-title":"Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2)","volume":"119","author":"Hinkes","year":"2007","journal-title":"Pediatrics."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00431-011-1668-2","article-title":"Educational paper: the podocytopathies","volume":"171","author":"B\u00fcscher","year":"2012","journal-title":"Eur J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-084620.23","article-title":"Management of children with congenital nephrotic syndrome: challenging treatment paradigms","author":"Dufek","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00467-018-4122-0","article-title":"Infants with congenital nephrotic syndrome have comparable outcomes to infants with other renal diseases On behalf of the ESPN Dialysis Working Group","volume":"34","author":"Dufek","year":"2019","journal-title":"Pediatr Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0022-3476(84)80418-7","article-title":"Congenital nephrotic syndrome: evolution of medical management and results of renal transplatation","volume":"105","author":"Mahan","year":"1984","journal-title":"J Pediatr"},{"key":"B11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.V32260","article-title":"Congenital nephrotic syndrome: preemptive bilateral nephrectomy and dyalisis before renal transplantation","volume":"3","author":"Kim","year":"1992","journal-title":"J Am Soc Nephrol."},{"key":"B12","first-page":"87","article-title":"S\u00edndromes nefr\u00f3ticos cong\u00e9nitos y hereditarios","volume":"83","author":"\u00c1lvarez","year":"2011","journal-title":"Rev Cubana Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/BF00856821","article-title":"Nephrotic syndrome in 1st year of life and the role of unilateral nephrectomy","volume":"6","author":"Mattoo","year":"1992","journal-title":"Pediatr Nephrol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00467-003-1131-3","article-title":"Management of congenital nephrotic syndrome","volume":"18","author":"Kovacevic","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1157\/13095849","article-title":"Evaluaci\u00f3n de las estrategias terap\u00e9uticas en el s\u00edndrome nefr\u00f3tico cong\u00e9nito tipo finland\u00e9s","volume":"65","author":"Gonz\u00e1lez","year":"2006","journal-title":"Anales Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/00008480-200404000-00009","article-title":"Recent advances in congenital nephrotic syndrome","volume":"16","author":"Papez","year":"2004","journal-title":"Curr Opin Pediatr"},{"key":"B17","first-page":"93","article-title":"El soporte nutricional en el \u00e1mbito de la hospitalizaci\u00f3n a domicilio","volume":"24","author":"Chicharro","year":"2009","journal-title":"Nutr Hosp."},{"key":"B18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1157\/13093998","article-title":"Eficiencia del tratamiento antibi\u00f3tico intravenoso domiciliario en la fibrosis qu\u00edstica","volume":"127","author":"Gir\u00f3n","year":"2006","journal-title":"Med Clin"},{"key":"B19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/pch\/16.2.105","article-title":"Home intravenous therapy: accessibility for Canadian children and youth | Position statements and practice points | Canadian Paediatric Society","volume":"16","author":"Moore","year":"2011","journal-title":"Paediatr Child Health"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s00467-015-3177-4","article-title":"Domiciliary administration of intravenous albumin in congenital nephrotic syndrome","volume":"30","author":"Reynolds","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/1076029618775514","article-title":"Catheter-directed thrombolysis with a continuous infusion of low-dose alteplase for subacute proximal venous thrombosis: efficacy and safety compared to urokinase","author":"Gong","year":"2018","journal-title":"Clin Appl Thromb"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.614535\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T16:28:56Z","timestamp":1670776136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.614535\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,14]]},"references-count":21,"alternative-id":["10.3389\/fped.2020.614535"],"URL":"https:\/\/doi.org\/10.3389\/fped.2020.614535","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,14]]},"article-number":"614535"}}